GENEVA, May 4 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/060719) for "SUBSTITUTED FUSED HETEROARYL LACTAM COMPOUNDS" on Oct 21, 2025. With publication no. WO/2026/088071, the details related to the patent application was published on Apr 30, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CASIMIRO GARCIA, Agustin (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), CHAPPIE, Thomas Allen (c/o Pfizer Inc.610 Main StreetCambridge, Massachusetts 02139), GREEN, Michael Eric (c/o Pfizer Inc.610 Main StreetCambridge, Mass...